News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
167,595 Results
Type
Article (6730)
Company Profile (131)
Press Release (160734)
Section
Business (54029)
Career Advice (352)
Deals (9807)
Drug Delivery (30)
Drug Development (32023)
Employer Resources (67)
FDA (2724)
Job Trends (4159)
News (96845)
Policy (6779)
Tag
Academia (259)
Alliances (12283)
Alzheimer's disease (359)
Approvals (2723)
Artificial intelligence (44)
Bankruptcy (61)
Best Places to Work (3234)
Biotechnology (85)
Breast cancer (38)
Cancer (418)
Career advice (302)
Cell therapy (88)
Clinical research (26708)
Collaboration (159)
Compensation (143)
COVID-19 (651)
C-suite (48)
Data (515)
Diabetes (45)
Diagnostics (584)
Earnings (22666)
Employer resources (59)
Events (33282)
Executive appointments (173)
FDA (2915)
Funding (119)
Gene therapy (45)
GLP-1 (214)
Government (712)
Healthcare (2293)
Infectious disease (673)
Inflammatory bowel disease (40)
Interviews (57)
IPO (5765)
Job creations (1029)
Job search strategy (260)
Layoffs (117)
Legal (907)
Lung cancer (68)
Manufacturing (85)
Medical device (448)
Medtech (449)
Mergers & acquisitions (4162)
Metabolic disorders (155)
Neuroscience (465)
NextGen Class of 2024 (979)
Non-profit (241)
Northern California (698)
Obesity (78)
Opinion (75)
People (17025)
Pharmaceutical (45)
Phase I (8077)
Phase II (12306)
Phase III (8986)
Pipeline (223)
Podcasts (35)
Policy (41)
Postmarket research (513)
Preclinical (3024)
Radiopharmaceuticals (107)
Rare diseases (69)
Real estate (1205)
Regulatory (5566)
Research institute (283)
Resumes & cover letters (40)
Southern California (582)
Startups (959)
United States (5400)
Vaccines (129)
Weight loss (43)
Date
Today (1)
Last 7 days (215)
Last 30 days (796)
Last 365 days (12623)
2024 (12556)
2023 (14387)
2022 (16256)
2021 (17925)
2020 (15281)
2019 (10080)
2018 (7202)
2017 (9001)
2016 (7372)
2015 (9341)
2014 (7087)
2013 (5103)
2012 (4935)
2011 (4867)
2010 (4844)
Location
Africa (171)
Asia (13327)
Australia (1449)
California (1486)
Canada (388)
China (185)
Colorado (53)
Connecticut (62)
Delaware (45)
Europe (24217)
Florida (159)
Georgia (44)
Illinois (69)
Indiana (52)
Japan (37)
Kansas (46)
Maryland (174)
Massachusetts (1192)
Minnesota (57)
New Jersey (527)
New York (511)
North Carolina (283)
Northern California (698)
Ohio (51)
Pennsylvania (280)
South America (213)
Southern California (582)
Texas (149)
Washington State (107)
167,595 Results for "arca biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma, Inc. reported first quarter 2024 financial results and provided a corporate update.
April 25, 2024
·
14 min read
Business
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2023 financial results and provided a corporate update.
February 1, 2024
·
6 min read
Deals
Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases
Paragon Therapeutics announced today that the third company founded based on assets generated by Paragon, Oruka Therapeutics (“Oruka”), has entered into a definitive agreement with ARCA biopharma to combine the companies in an all-stock transaction.
April 3, 2024
·
3 min read
Business
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
August 29, 2024
·
5 min read
Press Releases
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
August 19, 2024
·
11 min read
Business
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
August 26, 2024
·
9 min read
Press Releases
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
September 3, 2024
·
6 min read
Press Releases
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
August 26, 2024
·
10 min read
Business
ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 1, 2024
·
13 min read
Business
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported third quarter 2023 financial results and provided a corporate update.
October 18, 2023
·
5 min read
1 of 16,760
Next
